Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Drug cuts cardiovascular disease and lung cancer risk by reducing inflammation (CANTOS)

Science Daily - 27 Aug 2017 18:15
The IL-1? inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by reducing inflammation, according to late-breaking results.
Full Article at Science Daily

More Science News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard